Oct 2026
Early thyroid-stimulating hormone dynamics predict outcomes in advanced hepatocellular carcinoma treated with atezolizumab plus bevacizumab.
M. Matsumoto, T. Taniai, T. Uwagawa et al.
· Surgery today (Print) · 0 citations